Washington, DC - A secondary analysis of the Hemodialysis (HEMO) Study highlights the significant biases in trial results that can occur when as-treated vs intention-to-treat methodology is applied [ ...
VANCOUVER, Aug. 29 - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced that the U.S. Food and Drug Administration (FDA) has given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results